Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofia Ramiro

Showing results (221-230 of 287) with videos related to

Pageof 29
Sort By:
Annals of the Rheumatic Diseases|September 7, 2025
ASAS recommendations on reporting axial spondyloarthritis clinical trialsFloris A van Gaalen, Victoria Navarro-Compán, Xenofon Baraliakos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyXenofon Baraliakos, Atul Deodhar, Maxime Dougados, et al.
Acta Reumatologica Portuguesa|July 30, 2015
EpiReumaPt: how to perform a national population based study - a practical guideNélia Gouveia, Ana M Rodrigues, Sofia Ramiro, et al.
Journal of Medical Internet Research|January 10, 2023
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based SurveyYu Heng Kwan, Jie Kie Phang, Ting Hui Woon, et al.
Arthritis Research & Therapy|August 23, 2020
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?Santiago Rodrigues Manica, Alexandre Sepriano, Fernando Pimentel-Santos, et al.
Annals of the Rheumatic Diseases|January 17, 2024
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohortMary Lucy Marques, Sofia Ramiro, Miranda van Lunteren, et al.
ARP Rheumatology|July 8, 2023
Effectiveness of biosimilar infliximab CT-P13 compared to originator infliximab in biological-naïve patients with rheumatoid arthritis and axial spondyloarthritis: data from the Portuguese RegisterJosé Marona, Alexandre Sepriano, Sofia Ramiro, et al.
Arthritis Care & Research|August 3, 2016
Is the Site of Back Pain Related to the Location of Magnetic Resonance Imaging Lesions in Patients With Chronic Back Pain? Results From the Spondyloarthritis Caught Early CohortManouk de Hooge, Freek de Bruin, Lieke de Beer, et al.
RMD Open|October 1, 2019
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseasesAurélie Najm, Elena Nikiphorou, Marie Kostine, et al.
RMD Open|March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registryMauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Pageof 29

Showing results (221-230 of 287) with videos related to

Sort By:
Pageof 29
Annals of the Rheumatic Diseases|September 7, 2025
ASAS recommendations on reporting axial spondyloarthritis clinical trialsFloris A van Gaalen, Victoria Navarro-Compán, Xenofon Baraliakos, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 13, 2022
Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension StudyXenofon Baraliakos, Atul Deodhar, Maxime Dougados, et al.
Acta Reumatologica Portuguesa|July 30, 2015
EpiReumaPt: how to perform a national population based study - a practical guideNélia Gouveia, Ana M Rodrigues, Sofia Ramiro, et al.
Journal of Medical Internet Research|January 10, 2023
Social Media Use Among Members of the Assessment of Spondyloarthritis International Society: Results of a Web-Based SurveyYu Heng Kwan, Jie Kie Phang, Ting Hui Woon, et al.
Arthritis Research & Therapy|August 23, 2020
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?Santiago Rodrigues Manica, Alexandre Sepriano, Fernando Pimentel-Santos, et al.
Annals of the Rheumatic Diseases|January 17, 2024
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohortMary Lucy Marques, Sofia Ramiro, Miranda van Lunteren, et al.
ARP Rheumatology|July 8, 2023
Effectiveness of biosimilar infliximab CT-P13 compared to originator infliximab in biological-naïve patients with rheumatoid arthritis and axial spondyloarthritis: data from the Portuguese RegisterJosé Marona, Alexandre Sepriano, Sofia Ramiro, et al.
Arthritis Care & Research|August 3, 2016
Is the Site of Back Pain Related to the Location of Magnetic Resonance Imaging Lesions in Patients With Chronic Back Pain? Results From the Spondyloarthritis Caught Early CohortManouk de Hooge, Freek de Bruin, Lieke de Beer, et al.
RMD Open|October 1, 2019
EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseasesAurélie Najm, Elena Nikiphorou, Marie Kostine, et al.
RMD Open|March 5, 2026
Effectiveness of TNF inhibitors in patients with very early axial spondyloarthritis, defined as duration of ≤1 year of back pain: longitudinal observational data from the SCQM registryMauro Bachmann, Andrea Götschi, Annik Steimer, et al.
Pageof 29